Alpha Cognition Inc. Reports Second Quarter 2026 Financial Results and Provides Operational Update
· Financial Post
VANCOUVER, British Columbia & DALLAS -- Alpha Cognition Inc. (NASDAQ: ACOG) (“Alpha Cognition”, “ACI”, or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, today reported financial results for the second quarter ended June 30, 2026, and provided a business update. Read More
Visit turconews.click for more information.